CN116008530A - Preparation method and application of HRP (HRP) conjugated antibody dilution stabilizer - Google Patents
Preparation method and application of HRP (HRP) conjugated antibody dilution stabilizer Download PDFInfo
- Publication number
- CN116008530A CN116008530A CN202211705945.4A CN202211705945A CN116008530A CN 116008530 A CN116008530 A CN 116008530A CN 202211705945 A CN202211705945 A CN 202211705945A CN 116008530 A CN116008530 A CN 116008530A
- Authority
- CN
- China
- Prior art keywords
- hrp
- add
- solution
- preparation
- antibody dilution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003381 stabilizer Substances 0.000 title claims abstract description 50
- 238000010790 dilution Methods 0.000 title claims abstract description 40
- 239000012895 dilution Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims abstract description 12
- 102000004190 Enzymes Human genes 0.000 claims abstract description 12
- 230000001681 protective effect Effects 0.000 claims abstract description 12
- 238000001514 detection method Methods 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 7
- 239000003755 preservative agent Substances 0.000 claims abstract description 4
- 230000002335 preservative effect Effects 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 50
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 33
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 26
- 239000008367 deionised water Substances 0.000 claims description 26
- 229910021641 deionized water Inorganic materials 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 24
- 239000012498 ultrapure water Substances 0.000 claims description 24
- 239000003153 chemical reaction reagent Substances 0.000 claims description 22
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 18
- 239000003085 diluting agent Substances 0.000 claims description 18
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 18
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 18
- 235000011187 glycerol Nutrition 0.000 claims description 16
- 238000002372 labelling Methods 0.000 claims description 16
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 15
- 108010010803 Gelatin Proteins 0.000 claims description 14
- 239000002202 Polyethylene glycol Substances 0.000 claims description 14
- 229940098773 bovine serum albumin Drugs 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- 229920000159 gelatin Polymers 0.000 claims description 13
- 239000008273 gelatin Substances 0.000 claims description 13
- 235000019322 gelatine Nutrition 0.000 claims description 13
- 235000011852 gelatine desserts Nutrition 0.000 claims description 13
- 239000011780 sodium chloride Substances 0.000 claims description 13
- 238000005406 washing Methods 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 claims description 8
- 239000012086 standard solution Substances 0.000 claims description 8
- 238000011534 incubation Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000011550 stock solution Substances 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 230000002528 anti-freeze Effects 0.000 claims description 4
- 238000002835 absorbance Methods 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 230000009977 dual effect Effects 0.000 claims description 3
- 239000012224 working solution Substances 0.000 claims description 3
- 239000012089 stop solution Substances 0.000 claims description 2
- 239000007798 antifreeze agent Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 4
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 229920000136 polysorbate Polymers 0.000 abstract 1
- 238000003118 sandwich ELISA Methods 0.000 abstract 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 54
- 230000000052 comparative effect Effects 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 3
- 230000005965 immune activity Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
本发明公开了一种HRP偶联抗体稀释稳定剂的制备方法及其应用:先制备PBS缓冲液,再将保护蛋白、PEG、吐温、防腐剂加入其中,混匀后过滤除菌,即获得该HRP偶联抗体稀释稳定剂。这种稀释稳定剂能够有效减缓酶标抗体活性的降低,用于BSA夹心ELISA抗体检测试剂盒中酶标抗体的稀释保存,经稀释的酶标记抗体可在2–8℃保存至少12个月活性基本不发生改变。该稀释稳定剂也可用于一些常见酶标记抗体的稀释,从而长时间保持其生物活性。The invention discloses a preparation method and application of a HRP-coupled antibody dilution stabilizer: firstly prepare PBS buffer solution, then add protective protein, PEG, Tween and preservative into it, mix well and then filter and sterilize to obtain The HRP-conjugated antibody is diluted with stabilizer. This dilution stabilizer can effectively slow down the reduction of the enzyme-labeled antibody activity, and is used for the diluted storage of the enzyme-labeled antibody in the BSA sandwich ELISA antibody detection kit. The diluted enzyme-labeled antibody can be stored at 2–8°C for at least 12 months. Basically no change. This dilution stabilizer can also be used for the dilution of some common enzyme-labeled antibodies, so as to maintain their biological activity for a long time.
Description
技术领域technical field
本发明属于诊断生物制品技术领域,尤其是涉及一种HRP偶联抗体稀释稳定剂的制备方法及其在BSA检测试剂盒中的应用。The invention belongs to the technical field of diagnostic biological products, and in particular relates to a preparation method of an HRP-coupled antibody dilution stabilizer and its application in a BSA detection kit.
背景技术Background technique
酶偶联抗体,尤指辣根过氧化物酶(HRP)偶联抗体,一般只能将其原液在-20℃甚至更低的温度条件下储存且不能反复冻融,其免疫活性才能在一定时间(一般一年)内不会大幅降低,进而有效地保证检测方法结果的可靠性。近年来,大量研究表明,一些保护性蛋白、稳定剂等对酶偶联抗体的活性具有一点的保护作用。但是,大量应用实践证明,每一种酶偶联抗体稳定剂都不是广谱的,需要调整相关的配方来验证其作用。特别是对于BSA的检测,其酶偶联抗体的储存不能使用常规的保护性蛋白BSA。Enzyme-conjugated antibodies, especially horseradish peroxidase (HRP)-conjugated antibodies, generally can only be stored at -20°C or even lower temperatures and cannot be repeatedly frozen and thawed, so that their immune activity can be maintained at a certain level. Time (generally one year) will not be greatly reduced, thereby effectively ensuring the reliability of the detection method results. In recent years, a large number of studies have shown that some protective proteins, stabilizers, etc. have a little protective effect on the activity of enzyme-conjugated antibodies. However, a large number of applications have proved that each enzyme-conjugated antibody stabilizer is not broad-spectrum, and the relevant formula needs to be adjusted to verify its effect. Especially for the detection of BSA, the storage of its enzyme-conjugated antibody cannot use the conventional protective protein BSA.
因此探索研制一种可以有效保护BSA单抗酶偶联抗体火星在2-8℃甚至是室温条件下长期保存时其免疫活性不会发生大幅降低的稀释稳定剂,以保证试剂盒的稳定性,进而保证结果的准确性和操作的便捷性,对试剂盒商品化推广至关重要。Therefore, it was explored to develop a dilution stabilizer that can effectively protect the immune activity of the BSA monoclonal antibody enzyme-conjugated antibody Mars when it is stored at 2-8°C or even room temperature for a long time, so as to ensure the stability of the kit. Furthermore, ensuring the accuracy of the results and the convenience of operation is crucial to the commercialization of the kit.
发明内容Contents of the invention
相比于现有技术,本发明提供了一种HRP偶联抗体的稀释稳定剂,能够将经过稀释的HRP偶联抗体原液在2-8℃保存至少12个月。具体实施技术如下:Compared with the prior art, the present invention provides a dilution stabilizer of HRP-coupled antibody, which can preserve the diluted HRP-coupled antibody stock solution at 2-8°C for at least 12 months. The specific implementation techniques are as follows:
一种HRP偶联抗体稀释稳定剂的制备方法,其制备方法包括以下步骤:A preparation method of an HRP-coupled antibody dilution stabilizer, the preparation method comprising the following steps:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、保护蛋白1-10g、高分子聚合物1-2g,充分溶解后,加入表面活性剂0.5-1mL、防冻剂500mL、防腐剂0.3-0.5mL,充分混匀,用超纯水定容至1L,再用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300mL of ultrapure water, add 100mL of 10×PBS solution, 1-10g of protective protein, and 1-2g of high molecular polymer. After fully dissolving, add 0.5-1mL of surfactant, 500mL of antifreeze, and 0.3- 0.5mL, mix thoroughly, dilute to 1L with ultrapure water, and then filter and sterilize with a 0.2μm filter membrane to obtain the HRP-conjugated antibody dilution stabilizer.
优选地,步骤S2中所述保护蛋白为明胶,所述高分子聚合物为聚乙二醇(PEG),所述表面活性剂为吐温-20,所述防冻剂为甘油,所述防腐剂为Proclin-300。Preferably, the protective protein described in step S2 is gelatin, the polymer is polyethylene glycol (PEG), the surfactant is Tween-20, the antifreeze is glycerin, and the preservative For Proclin-300.
优选地,所述步骤S2为:每1L的HRP偶联抗体稀释稳定剂中含100mL10×PBS溶液、2g保护蛋白、1g高分子聚合物、0.5mL吐温-20、80mL甘油、0.5mLProclin-300。Preferably, the step S2 is: each 1L of HRP-conjugated antibody dilution stabilizer contains 100mL of 10×PBS solution, 2g of protective protein, 1g of high molecular weight polymer, 0.5mL of Tween-20, 80mL of glycerin, and 0.5mL of Proclin-300 .
本发明一个较佳实施例中,所述步骤S2为:往300mL超纯水中加入100mL10×PBS溶液、2g明胶、1g高分子聚合物,充分溶解后,加入0.5mL吐温-20、500mL甘油、0.5mL Proclin-300,充分混匀后超纯水定容至1L,0.2μm的滤膜过滤除菌得到稀释稳定剂。In a preferred embodiment of the present invention, the step S2 is: add 100mL of 10×PBS solution, 2g of gelatin, and 1g of polymer to 300mL of ultrapure water, and after fully dissolving, add 0.5mL of Tween-20 and 500mL of glycerin , 0.5mL Proclin-300, after mixing thoroughly, dilute to 1L with ultra-pure water, filter and sterilize through a 0.2μm filter membrane to obtain a diluted stabilizer.
本发明基于上述稀释稳定剂,将其用于牛血清白蛋白(BSA)检测试剂盒中,试剂盒包括抗BSA单抗包被微孔板、HRP标记试剂、HRP标记试剂稀释液、15倍浓缩洗液、样品稀释液、BSA标准溶液、TMB底物液和终止液。其中,所述HRP标记试剂是用该HRP偶联抗体稀释稳定剂将HRP偶联抗体原液按1:20稀释获得。The present invention is based on the above-mentioned dilution stabilizer, which is used in bovine serum albumin (BSA) detection kits, which include anti-BSA monoclonal antibody coated microwell plates, HRP labeling reagents, HRP labeling reagent dilutions, 15 times concentrated Wash solution, sample diluent, BSA standard solution, TMB substrate solution and stop solution. Wherein, the HRP labeling reagent is obtained by diluting the HRP-conjugated antibody stock solution by 1:20 with the HRP-conjugated antibody dilution stabilizer.
优选地,所述牛血清白蛋白(BSA)检测试剂盒的具体使用方法为:Preferably, the specific method of use of the bovine serum albumin (BSA) detection kit is:
P1:取出试剂盒,所有试剂在室温平衡30min。P1: Take out the kit, and equilibrate all reagents at room temperature for 30 minutes.
P2:取出包被微孔板,每孔加入350μL洗液洗板,重复2次。P2: Take out the coated microwell plate, add 350 μL of washing solution to each well to wash the plate, and repeat 2 times.
P3:逐孔加入0、5、10、20、30、40、50、60ng/mL标准溶液和待测样品,50μL/孔。。P3: Add 0, 5, 10, 20, 30, 40, 50, 60ng/mL standard solutions and samples to be tested one by one, 50 μL/well. .
P4:封板膜封好,25℃避光静置孵育1小时。P4: Seal the plate with a sealing film, and incubate for 1 hour at 25°C in the dark.
P5:孵育结束,弃掉酶标板孔内液体,每孔加入350μL洗液洗板,重复2次。P5: At the end of the incubation, discard the liquid in the wells of the enzyme labeling plate, add 350 μL of washing solution to each well to wash the plate, and repeat 2 times.
P6:每孔加入100μL用HRP标记试剂稀释液稀释好的HRP标记抗体工作液。P6: Add 100 μL of HRP-labeled antibody working solution diluted with HRP-labeled reagent diluent to each well.
P7:封板膜封好,25℃避光静置孵育30min。P7: Seal the plate with the sealing film, and incubate at 25°C in the dark for 30 minutes.
P8:孵育结束,弃掉酶标板孔内液体,每孔加入350μL洗液洗板,重复4次。P8: After incubation, discard the liquid in the microplate wells, add 350 μL of washing solution to each well to wash the plate, and repeat 4 times.
P9:每孔加入50μLTMB底物液,25℃静置避光反应15分钟。P9: Add 50 μL TMB substrate solution to each well, and let it stand at 25°C in the dark for 15 minutes.
P10:每孔加入50μL反应终止液。P10: Add 50 μL of reaction termination solution to each well.
P11:使用酶标仪双波长(450nm和630nm)读取吸光值。P11: Use a microplate reader to read the absorbance at dual wavelengths (450nm and 630nm).
本发明解决了背景技术中存在的缺陷,本发明具备以下有益效果:本发明提供的HRP偶联抗体的稀释稳定剂,含有保护性蛋白明胶、高分子聚合物PEG、表面活性剂吐温-20、防冻剂甘油、防腐剂Proclin-300,五者相互补充,经本稀释稳定剂稀释获得HRP标记试剂在2-8℃可保存12个月。在试剂盒领域中,采用这五种试剂联用的方式,在文献及专利中未见报道。The present invention solves the defects existing in the background technology, and the present invention has the following beneficial effects: the dilution stabilizer of the HRP-coupled antibody provided by the present invention contains protective protein gelatin, high molecular polymer PEG, and surfactant Tween-20 , antifreeze glycerin, and preservative Proclin-300, the five complement each other, and the HRP labeling reagent obtained by diluting this dilution stabilizer can be stored at 2-8°C for 12 months. In the field of reagent kits, the combination of these five reagents has not been reported in literature and patents.
具体实施方式Detailed ways
为了能够更清楚地理解本发明的上述目的、特征和优点,下面具体实施方式对本发明进行进一步的详细描述。需要说明的是,在不冲突的情况下,本申请的实施例及实施例中的特征可以相互组合。In order to more clearly understand the above objects, features and advantages of the present invention, the following specific embodiments will further describe the present invention in detail. It should be noted that, in the case of no conflict, the embodiments of the present application and the features in the embodiments can be combined with each other.
显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围,在下面的描述中阐述了很多具体细节以便于充分理解本发明,但是,本发明还可以采用其他不同于在此描述的其他方式来实施,因此,本发明的保护范围并不受下面公开的具体实施例的限制。Apparently, the described embodiments are only some of the embodiments of the present invention, but not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative work, all belong to the protection scope of the present invention, and many specific details are set forth in the following description so as to fully Understand the present invention, however, the present invention can also be implemented in other ways than those described here, therefore, the protection scope of the present invention is not limited by the specific embodiments disclosed below.
以下实施例和比较例中,所用的明胶、PEG、Proclin-300购自Sigma公司,甘油、吐温-20购自国药集团。In the following examples and comparative examples, the gelatin, PEG, and Proclin-300 used were purchased from Sigma, and glycerin and Tween-20 were purchased from Sinopharm.
以下应用例中,试剂盒的使用方法为:In the following application examples, the method of using the kit is as follows:
P1:取出试剂盒,所有试剂在室温平衡30min。P1: Take out the kit, and equilibrate all reagents at room temperature for 30 minutes.
P2:取出包被微孔板,每孔加入350μL洗液洗板,重复2次。P2: Take out the coated microwell plate, add 350 μL of washing solution to each well to wash the plate, and repeat 2 times.
P3:逐孔加入0、5、10、20、30、40、50、60ng/mL标准溶液和待测样品,50μL/孔。。P3: Add 0, 5, 10, 20, 30, 40, 50, 60ng/mL standard solutions and samples to be tested one by one, 50 μL/well. .
P4:封板膜封好,25℃避光静置孵育1小时。P4: Seal the plate with a sealing film, and incubate for 1 hour at 25°C in the dark.
P5:孵育结束,弃掉酶标板孔内液体,每孔加入350μL洗液洗板,重复2次。P5: At the end of the incubation, discard the liquid in the wells of the enzyme labeling plate, add 350 μL of washing solution to each well to wash the plate, and repeat 2 times.
P6:每孔加入100μL用HRP标记试剂稀释液稀释好的HRP标记抗体工作液。P6: Add 100 μL of HRP-labeled antibody working solution diluted with HRP-labeled reagent diluent to each well.
P7:封板膜封好,25℃避光静置孵育30min。P7: Seal the plate with the sealing film, and incubate at 25°C in the dark for 30 minutes.
P8:孵育结束,弃掉酶标板孔内液体,每孔加入350μL洗液洗板,重复4次。P8: After incubation, discard the liquid in the microplate wells, add 350 μL of washing solution to each well to wash the plate, and repeat 4 times.
P9:每孔加入50μLTMB底物液,25℃静置避光反应15分钟。P9: Add 50 μL TMB substrate solution to each well, and let it stand at 25°C in the dark for 15 minutes.
P10:每孔加入50μL反应终止液。P10: Add 50 μL of reaction termination solution to each well.
P11:使用酶标仪双波长(450nm和630nm)读取吸光值。P11: Use a microplate reader to read the absorbance at dual wavelengths (450nm and 630nm).
实施例1Example 1
本实施例提供的HRP偶联抗体的稳定稀释剂,其制备方法为:The stable diluent of the HRP-conjugated antibody provided in this example, its preparation method is:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、2g明胶、1gPEG,充分溶解后,加入0.5mL吐温-20、500mL甘油、0.5mLProclin-300,充分混匀,用超纯水定容至1L后,用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300mL of ultrapure water, add 100mL of 10×PBS solution, 2g of gelatin, and 1g of PEG. After fully dissolving, add 0.5mL of Tween-20, 500mL of glycerin, and 0.5mL of Proclin-300, mix well, and set After the volume was reduced to 1 L, filter and sterilize with a 0.2 μm filter membrane to obtain the HRP-conjugated antibody dilution stabilizer.
实施例2Example 2
本实施例提供的HRP偶联抗体的稳定稀释剂,其制备方法为:The stable diluent of the HRP-conjugated antibody provided in this example, its preparation method is:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、2g明胶、1gPEG,充分溶解后,加入0.5mL吐温-20、500mL甘油、0.3mLProclin-300,充分混匀,用超纯水定容至1L后,用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300mL of ultrapure water, add 100mL of 10×PBS solution, 2g of gelatin, and 1g of PEG. After fully dissolving, add 0.5mL of Tween-20, 500mL of glycerin, and 0.3mL of Proclin-300, mix well, and set After the volume was reduced to 1 L, filter and sterilize with a 0.2 μm filter membrane to obtain the HRP-conjugated antibody dilution stabilizer.
实施例3Example 3
本实施例提供的HRP偶联抗体的稳定稀释剂,其制备方法为:The stable diluent of the HRP-conjugated antibody provided in this example, its preparation method is:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、2g明胶、1gPEG,充分溶解后,加入1mL吐温-20、500mL甘油、0.5mLProclin-300,充分混匀,用超纯水定容至1L后,用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300mL of ultrapure water, add 100mL of 10×PBS solution, 2g of gelatin, and 1g of PEG. After fully dissolving, add 1mL of Tween-20, 500mL of glycerin, and 0.5mL of Proclin-300, mix well, and dilute to volume with ultrapure water After reaching 1 L, filter and sterilize with a 0.2 μm filter membrane to obtain the HRP-conjugated antibody dilution stabilizer.
实施例4Example 4
本实施例提供的HRP偶联抗体的稳定稀释剂,其制备方法为:The stable diluent of the HRP-conjugated antibody provided in this example, its preparation method is:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、2g明胶、2gPEG,充分溶解后,加入0.5mL吐温-20、500mL甘油、0.5mLProclin-300,充分混匀,用超纯水定容至1L后,用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300mL of ultrapure water, add 100mL of 10×PBS solution, 2g of gelatin, and 2g of PEG. After fully dissolving, add 0.5mL of Tween-20, 500mL of glycerin, and 0.5mL of Proclin-300. After the volume was reduced to 1 L, filter and sterilize with a 0.2 μm filter membrane to obtain the HRP-conjugated antibody dilution stabilizer.
实施例5Example 5
本实施例提供的HRP偶联抗体的稳定稀释剂,其制备方法为:The stable diluent of the HRP-conjugated antibody provided in this example, its preparation method is:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、5g明胶、1gPEG,充分溶解后,加入0.5mL吐温-20、500mL甘油、0.5mLProclin-300,充分混匀,用超纯水定容至1L后,用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300 mL of ultrapure water, add 100 mL of 10×PBS solution, 5 g of gelatin, and 1 g of PEG. After fully dissolving, add 0.5 mL of Tween-20, 500 mL of glycerin, and 0.5 mL of Proclin-300. After the volume was reduced to 1 L, filter and sterilize with a 0.2 μm filter membrane to obtain the HRP-conjugated antibody dilution stabilizer.
实施例6Example 6
本实施例提供的HRP偶联抗体的稳定稀释剂,其制备方法为:The stable diluent of the HRP-conjugated antibody provided in this example, its preparation method is:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、10g明胶、1gPEG,充分溶解后,加入0.5mL吐温-20、500mL甘油、0.5mLProclin-300,充分混匀,用超纯水定容至1L后,用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300mL of ultrapure water, add 100mL of 10×PBS solution, 10g of gelatin, and 1g of PEG. After fully dissolving, add 0.5mL of Tween-20, 500mL of glycerin, and 0.5mL of Proclin-300, mix well, and set After the volume was reduced to 1 L, filter and sterilize with a 0.2 μm filter membrane to obtain the HRP-conjugated antibody dilution stabilizer.
对比例1Comparative example 1
本比较例提供的HRP偶联抗体的稳定稀释剂,其制备方法为:The stable diluent of HRP conjugated antibody provided in this comparative example, its preparation method is:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、2g明胶、1gPEG,充分溶解后,加入0.5mL吐温-20、0.5mLProclin-300,充分混匀,用超纯水定容至1L后,用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300mL of ultrapure water, add 100mL of 10×PBS solution, 2g of gelatin, and 1g of PEG. After fully dissolving, add 0.5mL of Tween-20 and 0.5mL of Proclin-300, mix well, and dilute to 1L with ultrapure water Afterwards, filter and sterilize with a 0.2 μm filter membrane to obtain the HRP-conjugated antibody dilution stabilizer.
对比例2Comparative example 2
本比较例提供的HRP偶联抗体的稳定稀释剂,其制备方法为:The stable diluent of HRP conjugated antibody provided in this comparative example, its preparation method is:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、1gPEG,充分溶解后,加入0.5mL吐温-20、500mL甘油、0.5mLProclin-300,充分混匀,用超纯水定容至1L后,用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300mL of ultrapure water, add 100mL of 10×PBS solution, 1g of PEG, after fully dissolved, add 0.5mL of Tween-20, 500mL of glycerin, 0.5mL of Proclin-300, mix well, and dilute to 1L with ultrapure water Afterwards, filter and sterilize with a 0.2 μm filter membrane to obtain the HRP-conjugated antibody dilution stabilizer.
对比例3Comparative example 3
本比较例提供的HRP偶联抗体的稳定稀释剂,其制备方法为:The stable diluent of HRP conjugated antibody provided in this comparative example, its preparation method is:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、2g明胶,充分溶解后,加入0.5mL吐温-20、500mL甘油、0.5mLProclin-300,充分混匀,用超纯水定容至1L后,用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300mL of ultrapure water, add 100mL of 10×PBS solution, 2g of gelatin, after fully dissolved, add 0.5mL of Tween-20, 500mL of glycerin, 0.5mL of Proclin-300, mix well, and dilute to After 1 L, filter and sterilize with a 0.2 μm filter membrane to obtain the HRP-conjugated antibody dilution stabilizer.
对比例4Comparative example 4
本比较例提供的HRP偶联抗体的稳定稀释剂,其制备方法为:The stable diluent of HRP conjugated antibody provided in this comparative example, its preparation method is:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、0.5mL吐温-20、500mL甘油、0.5mLProclin-300,充分混匀,用超纯水定容至1L后,用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300mL of ultrapure water, add 100mL of 10×PBS solution, 0.5mL of Tween-20, 500mL of glycerin, and 0.5mL of Proclin-300, mix thoroughly, dilute to 1L with ultrapure water, and filter with 0.2μm Sterilize by membrane filtration to obtain the HRP-conjugated antibody dilution stabilizer.
对比例5Comparative example 5
本比较例提供的HRP偶联抗体的稳定稀释剂,其制备方法为:The stable diluent of HRP conjugated antibody provided in this comparative example, its preparation method is:
步骤S1:将NaCl80g、KCl2g、Na2HPO414.2g、KH2PO42.7g加入800mL去离子水中,待完全溶解后,调节pH至7.2,之后加去离子水定容至1L,获得10×PBS溶液;Step S1: Add 80g of NaCl, 2g of KCl, 14.2g of Na 2 HPO 4 , and 2.7g of KH 2 PO 4 into 800mL of deionized water. After completely dissolving, adjust the pH to 7.2, and then add deionized water to make it up to 1L to obtain 10× PBS solution;
步骤S2:取超纯水300mL,加入10×PBS溶液100mL、0.5mL吐温-20,充分混匀,用超纯水定容至1L后,用0.2μm的滤膜过滤除菌,得到HRP偶联抗体稀释稳定剂。Step S2: Take 300 mL of ultrapure water, add 100 mL of 10×PBS solution and 0.5 mL of Tween-20, mix thoroughly, and dilute to 1 L with ultrapure water, then filter and sterilize with a 0.2 μm filter membrane to obtain HRP pair Antibody dilution stabilizer.
对比例6Comparative example 6
本比较例提供的HRP偶联抗体的稳定稀释剂,为市售的HRP偶联抗体稳定剂,具体配方不详。The stabilizing diluent for the HRP-conjugated antibody provided in this comparative example is a commercially available HRP-conjugated antibody stabilizer, and the specific formula is unknown.
应用例1:Application example 1:
利用实施例1-6和对比例1-6制备的稀释稳定剂对HRP偶联抗体原液按照1:20进行稀释,获得HRP标记试剂,对其进行37℃加速破坏实验,每2天检测一次,共检测5次。以此检验实施例1-6和对比例1-6制备的稀释稳定剂对HRP偶联抗体的保护性,具体结果如表1所示。Use the diluted stabilizer prepared in Examples 1-6 and Comparative Examples 1-6 to dilute the stock solution of the HRP-conjugated antibody at 1:20 to obtain the HRP-labeled reagent, which is subjected to an accelerated destruction test at 37°C and tested once every 2 days. A total of 5 tests were performed. In this way, the protection of the diluted stabilizers prepared in Examples 1-6 and Comparative Examples 1-6 to HRP-conjugated antibodies was tested, and the specific results are shown in Table 1.
表1:37℃加速破坏实验中BSA标准溶液60、0ng/mL的OD值Table 1: OD value of BSA standard solution 60, 0ng/mL in accelerated destruction test at 37°C
通过表1可知,实施例1制备的稀释稳定剂,在37℃加速破坏实验中对HRP偶联抗体的保护性明显优于实施例2-6和对比例1-6。实施例2-6尽管有一定的保护效果,但其60ng/mL时的信号值较低。对比例1信号值较弱。对比例2、4和5保护效果较差。对比例3和6虽有较好的保护效果,但0ng/mL时背景值较高,导致信噪比明显低于实施例1。It can be seen from Table 1 that the diluted stabilizer prepared in Example 1 is significantly better than Examples 2-6 and Comparative Examples 1-6 in protecting HRP-conjugated antibodies in the accelerated destruction test at 37°C. Although Examples 2-6 have a certain protective effect, the signal value at 60ng/mL is relatively low. The signal value of Comparative Example 1 is relatively weak. Comparative examples 2, 4 and 5 have poor protection effects. Although Comparative Examples 3 and 6 have better protective effects, the background value is higher at 0 ng/mL, resulting in a significantly lower signal-to-noise ratio than Example 1.
应用例2:应用稀释稳定剂稀释的HRP标记试剂在2-8℃下的保存期实验Application example 2: The storage life experiment of HRP labeling reagent diluted with dilution stabilizer at 2-8°C
选取实施例1-6和对比例1-6制备的稀释稳定剂对HRP偶联抗体原液按照1:20进行稀释,获得HRP标记试剂,于2-8℃保存备用。The diluted stabilizer prepared in Examples 1-6 and Comparative Examples 1-6 was selected to dilute the stock solution of HRP-conjugated antibody at 1:20 to obtain HRP labeling reagent, which was stored at 2-8°C for later use.
实验1:标准溶液60、0ng/mL测试实验Experiment 1: Standard solution 60, 0ng/mL test experiment
每隔1-2个月取出HRP标记试剂,按照实验检测方法进行测试,共测试12个月。检测结果如表2所示。Take out the HRP labeling reagent every 1-2 months, and test it according to the experimental detection method for a total of 12 months. The test results are shown in Table 2.
表2:4℃保存的HRP标记试剂测试标准溶液60、0ng/mL的结果Table 2: Results of HRP labeling reagent test standard solution 60, 0ng/mL stored at 4°C
实验2:物理性状实验Experiment 2: Physical Properties Experiment
(1)溶液澄清度检测:将采用实施例1制备的稀释稳定剂制备的HRP标记试剂于2-8℃保存。每隔1月检测一共12个月,观察其是否为澄清容易。结果显示均为澄清溶液。(1) Detection of solution clarity: the HRP labeling reagent prepared by using the diluted stabilizer prepared in Example 1 was stored at 2-8°C. Test every 1 month for a total of 12 months to see if it is easy to clear. The results showed that all were clear solutions.
(2)无菌检验:将采用实施例1制备的稀释稳定剂制备的HRP标记试剂于2-8℃保存。每隔1月接种于平板,置于37℃培养。共计培养观察7天,共计检验12个月。检验结果均为无菌。(2) Sterility test: the HRP labeling reagent prepared by using the diluted stabilizer prepared in Example 1 was stored at 2-8°C. They were inoculated on plates every 1 month and cultured at 37°C. A total of 7 days of culture and observation, a total of 12 months of inspection. The test results were all sterile.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211705945.4A CN116008530A (en) | 2022-12-29 | 2022-12-29 | Preparation method and application of HRP (HRP) conjugated antibody dilution stabilizer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211705945.4A CN116008530A (en) | 2022-12-29 | 2022-12-29 | Preparation method and application of HRP (HRP) conjugated antibody dilution stabilizer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116008530A true CN116008530A (en) | 2023-04-25 |
Family
ID=86035744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211705945.4A Pending CN116008530A (en) | 2022-12-29 | 2022-12-29 | Preparation method and application of HRP (HRP) conjugated antibody dilution stabilizer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116008530A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117007791A (en) * | 2023-07-18 | 2023-11-07 | 广州市进德生物科技有限公司 | Horseradish peroxidase conjugate dilution preservation solution |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102628863A (en) * | 2012-04-19 | 2012-08-08 | 上海蓝怡科技有限公司 | Alkaline phosphatase labeled antigen-antibody diluent |
CN106405095A (en) * | 2015-07-28 | 2017-02-15 | 南京农业大学 | Detection of animal-derived allergen bovine serum albumin by using indirect competitive ELISA method |
CN109557302A (en) * | 2018-12-04 | 2019-04-02 | 蓝怡科技集团股份有限公司 | A kind of preparation method and application of microballoon reagent |
-
2022
- 2022-12-29 CN CN202211705945.4A patent/CN116008530A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102628863A (en) * | 2012-04-19 | 2012-08-08 | 上海蓝怡科技有限公司 | Alkaline phosphatase labeled antigen-antibody diluent |
CN106405095A (en) * | 2015-07-28 | 2017-02-15 | 南京农业大学 | Detection of animal-derived allergen bovine serum albumin by using indirect competitive ELISA method |
CN109557302A (en) * | 2018-12-04 | 2019-04-02 | 蓝怡科技集团股份有限公司 | A kind of preparation method and application of microballoon reagent |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117007791A (en) * | 2023-07-18 | 2023-11-07 | 广州市进德生物科技有限公司 | Horseradish peroxidase conjugate dilution preservation solution |
CN117007791B (en) * | 2023-07-18 | 2024-08-09 | 广州市进德生物科技有限公司 | Horseradish peroxidase conjugate dilution preservation solution |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103364568B (en) | Laminin nano-magnetic particle chemiluminescent immunity quantitative detection kit and preparation method thereof | |
JPH11246593A6 (en) | Protection of proteins and the like | |
CN116008530A (en) | Preparation method and application of HRP (HRP) conjugated antibody dilution stabilizer | |
US10520486B2 (en) | Method for suppressing protein adsorption | |
CN113717282A (en) | Antibody diluent | |
WO2019169797A1 (en) | Composition for enzyme-linked immunosorbent assay kit, anti-nuclear antibody repertoire detection kit and preparation method therefor | |
WO2014021387A1 (en) | Latex agglutination inhibition immunoassay | |
CN115774112A (en) | 25-hydroxy vitamin D dissociation liquid, detection method, application and kit | |
CN103575908B (en) | The detection method of collagen in a kind of ancient cultural relic material | |
CN108267579A (en) | Stablize and preserve dilution, antinuclear antibody detection reagent and its preparation method and application | |
CN107043762A (en) | A kind of preserving stabilizer and its store method for improving horseradish peroxidase storage stability | |
BR112016024624B1 (en) | COMBINATION PRODUCT FOR DETECTING TARGET MARKER, METHOD FOR DETECTING A TARGET MARKER IN A BIOLOGICAL SAMPLE OBTAINED FROM AN INDIVIDUAL, AND USE OF A COMBINATION PRODUCT FOR DETECTING A TARGET MARKER IN A BIOLOGICAL SAMPLE | |
WO2021232714A1 (en) | Enzyme-linked immunosorbent assay test kit for novel coronavirus igm antibody | |
Sakaki et al. | Water-soluble 2-methacryloyloxyethyl phosphorylcholine copolymer as a novel synthetic blocking reagent in immunoassay system | |
CN112198036A (en) | An improved immunohistochemical staining method for paraffin sections of porcine brain tissue | |
CN101042399A (en) | Diabetes autoantibody immunoblotting reagent kit | |
CN115078711A (en) | Cleaning fluid for flow-type fluorescence detection | |
WO2019169798A1 (en) | Composition for enzyme-linked immunosorbent assay kit, diabetes antibody repertoire detection kit and preparation method therefor | |
EP3279660B1 (en) | Preservative solution for heme protein, and method for stabilizing heme protein | |
CN113238038A (en) | Antibody diluent for immunohistochemical detection and preparation method and application thereof | |
CN114755410A (en) | Alkaline phosphatase labeled antibody reagent | |
CN113985029A (en) | Composition suitable for improving stability of immunoturbidimetric reagent | |
WO2009122592A1 (en) | Kit for detecting viral antigen and viral antibody including reagent storable at room temperature and method for detecting viral antigen and viral antibody | |
CN107602687B (en) | Troponin preservative and preservative composition | |
Crowther et al. | Evaluation of the use of chromogenic and fluorogenic substrates in solid-phase enzyme linked immunosorbent assays (ELISA) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |